Correlation Between Gold Rain and GeneReach Biotechnology

Can any of the company-specific risk be diversified away by investing in both Gold Rain and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gold Rain and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gold Rain Enterprises and GeneReach Biotechnology, you can compare the effects of market volatilities on Gold Rain and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gold Rain with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gold Rain and GeneReach Biotechnology.

Diversification Opportunities for Gold Rain and GeneReach Biotechnology

-0.41

Correlation Coefficient

Gold Rain  GeneReach Biotechnology

Very good diversification

The 3 months correlation between Gold and GeneReach is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Gold Rain Enterprises and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Gold Rain is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gold Rain Enterprises are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Gold Rain i.e., Gold Rain and GeneReach Biotechnology go up and down completely randomly.

Pair Corralation between Gold Rain and GeneReach Biotechnology

Assuming the 90 days trading horizon Gold Rain is expected to generate 17.19 times less return on investment than GeneReach Biotechnology. In addition to that, Gold Rain is 1.51 times more volatile than GeneReach Biotechnology. It trades about 0.01 of its total potential returns per unit of risk. GeneReach Biotechnology is currently generating about 0.19 per unit of volatility. If you would invest  2,580  in GeneReach Biotechnology on October 16, 2024 and sell it today you would earn a total of  215.00  from holding GeneReach Biotechnology or generate 8.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Gold Rain Enterprises  vs.  GeneReach Biotechnology

Gold Rain Enterprises

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Gold Rain Enterprises are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Gold Rain may actually be approaching a critical reversion point that can send shares even higher in February 2025.

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, GeneReach Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Gold Rain and GeneReach Biotechnology

The main advantage of trading using opposite Gold Rain and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gold Rain position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.

The idea behind Gold Rain Enterprises and GeneReach Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.